Stay updated on Amcenestrant in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Amcenestrant in ER+ Breast Cancer Clinical Trial page.

Latest updates to the Amcenestrant in ER+ Breast Cancer Clinical Trial page
- Check2 days agoChange DetectedThe revision identifier in the footer changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check9 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1 while the 403 error page remained otherwise unchanged.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the full study content, blocking viewing of the records and documents. A minimal 403 page with a Home link and a Revision banner replaces the former detailed study information and attachments.SummaryDifference23%

- Check50 days agoChange DetectedThe study record now includes the 2017 (U.S. NIH Grant/Contract) identifier and the page revision has been updated to v3.6.6, replacing v3.6.5 in the revision history.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page now shows Revision: v3.6.5, updating the page version. It indicates a metadata update rather than a change to the study data or other visible content.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page shows a new revision tag 'Revision: v3.6.4' replacing the previous 'Revision: v3.6.3', indicating a small update to the page version rather than changes to study details.SummaryDifference0.0%

Stay in the know with updates to Amcenestrant in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amcenestrant in ER+ Breast Cancer Clinical Trial page.